$MTH

Meritage Homes CORP

Meritage Homes designs and builds single-family attached and detached homes, primarily for entry-level and first move-up buyers. It operates homebuilding segments in the West, Central and East regions, across twelve states, and sells homes under the Meritage Homes name. At December 31, 2025, it was actively selling homes in 336 communities. Its financial services segment offers homebuyers title and escrow, mortgage, and insurance services. Carefree Title provides title insurance and closing services, Meritage Insurance offers homeowners and other insurance products, and a mortgage joint venture primarily serves Meritage homebuyers. Meritage makes money by selling completed homes and providing related financial services; it also sells land and lots to other developers and homebuilders from time to time. Its homebuilding operations use a 100% speculative homebuilding strategy, with homes built from preselected plans and features. Meritage Homes Corporation is headquartered in Scottsdale, Arizona, and operates as a holding company; its construction, development and sales activities are conducted through subsidiaries.

0
0
1

No SEC Form 4 filings for $MTH in the last 30 days.

See all $MTH insider activity →
Med

US real estate stocks slide as hotter inflation fuels Fed rate-hike bets

US real estate and homebuilding stocks declined as inflation data increased expectations for Fed rate hikes. The 2-year Treasury yield rose to 4.75%, and the 10-year yield climbed to 5%. Lennar, Meritage, PulteGroup, DR Horton, and Toll Brothers saw significant share price drops. Analysts note that higher mortgage rates may reduce housing affordability.

MTH sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning MTH (Meritage Homes CORP). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.

Recent MTH coverage spans financial news, earnings and market movers.

What's driving MTH

  • Meritage expected to see weaker sales and margin compression.

    aa.com.tr · Nov 11, 2026

  • UBS kept its Buy rating on Meritage Homes but reduced its price target to $85 from $88, citing a 3.4% decrease. The new target suggests a 31.8% upside from the Oct 30 close of $64.47. Recent analyst price targets for the company range from $59 to $82.

    tradingview.com · Oct 31, 2026

  • Truist Securities kept Meritage Homes at Hold, reducing its price target to $65 from $72, a 9.7% decrease. The new target aligns with the stock's recent closing price of $64.49. Other analysts' targets for the company range from $59 to $82.

    tradingview.com · Oct 30, 2026

  • Evercore ISI Group kept Meritage Homes at In-Line but reduced its price target to $64 from $65, a 1.5% decrease. The new target is close to the stock's Oct 29 closing price of $64.49.

    tradingview.com · Oct 30, 2026

  • Earnings miss likely triggers sell pressure.

    tradingview.com · Oct 28, 2026

AlphAI scores every news story that mentions MTH with an AI model for sentiment and relevance, and aggregates insider trades from Meritage Homes CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $MTH

Score

US real estate stocks slide as hotter inflation fuels Fed rate-hike bets

US real estate and homebuilding stocks declined as inflation data increased expectations for Fed rate hikes. The 2-year Treasury yield rose to 4.75%, and the 10-year yield climbed to 5%. Lennar, Meritage, PulteGroup, DR Horton, and Toll Brothers saw significant share price drops. Analysts note that higher mortgage rates may reduce housing affordability.

$MTHMedEarnings

Meritage Homes reports third quarter 2026 results

Meritage Homes CORP (MTH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contacts: Emily Tadano, VP Investor Relations and External Communications (480) 515-8979 (office) investors@meritagehomes.com Meritage Homes reports third quarter 2026 results SCOTTSDALE, Ariz., October 28, 2026 - Meritage Homes Corporation (NYSE: MTH), the fifth-lar

Starbucks initiated, Expedia downgraded: Wall Street's top analyst calls

Analysts made several rating changes: Wolfe upgraded Paychex (PAYX) citing stable employment trends. UBS upgraded Union Pacific (UNP) to Buy with a $339 price target, expecting strong 2027 volume growth. Needham upgraded Rocket Pharmaceuticals (RCKT) to Buy with a $9 target after FDA reaffirmed study design. JPMorgan upgraded Credicorp (BAP) to Overweight with a $482 target, seeing strong EPS growth. Morgan Stanley downgraded Expedia (EXPE) to Underweight with a $235 target, citing weaker assets

Why is Meritage Homes stock sliding today?

Meritage Homes (MTH) fell 2.3% premarket after Truist Securities downgraded it from Buy to Hold, cutting its price target to $72 from $80. The firm had previously rated it Buy with a $90 target. MTH's net income dropped 38% YoY last quarter, and the sector faces high mortgage rates and material costs. Competitors like D.R. Horton, Lennar, and PulteGroup also struggle with these issues.

Related tickers